We are very pleased to announce that Neurosoft Bioelectronics has passed stage 2 of Venture Kick and received a second round of funding of 40 000 CHF. The Venture Kick jury has selected our project to receive the second “kick” and has chosen to support us in further...

During the 2020 >>venture>> award ceremony, Neurosoft Bioelectronics was ranked 2nd in the Health & Nutrition category. We were one of the three finalists (along with Urodea and NextKidney) out of 89 initial applicants in our vertical.The >>venture>> competition...

Neurosoft Bioelectronics was selected to participate in the MassChallenge Switzerland 2020 accelerator program. We were one of over 1’000 other startups to apply for the accelerator located in Lausanne, Switzerland. This program will allow us to engage with industry...

Neurosoft Bioelectronics is thrilled and proud to announce that it was one of three projects selected for funding through the Catalyze4Life (C4L) competition, organized by EPFL’s School of Life Sciences to identify innovative research projects across EPFL. “The...

We are very proud to have been selected as a finalist for the 2020 >>venture>> competition in the Health & Nutrition vertical! >>venture>> is providing us access to a wide network of experts in the Swiss startup scene, and to mentors and...

We are one of the two startups selected to fly to the Silicon Valley in 2020! The competition started in October 2019 and confronted healthcare companies from all over Switzerland. A jury selected the 10 top startups who were split in two clusters. In the second...

We were selected among 60 applicants from all over Switzerland as one of the best life science startups. The jury of investors and experts selected the 10 participants developing the most outbreaking solutions in their field. With the other finalists, we will...

Born in South Korea, Sukho Song completed his master’s degree in 2007 at Tohoku University in Japan as a mechanical engineer specialized in micro/nanofabrication. He obtained his PhD degree from Carnegie Mellon University in 2017, where he focused on the development...

It is often a long and laborious process to bring a new technology from the laboratory to the market. According to Stephanie Lacour, head of the Laboratory for Soft Bioelectronic Interfaces (LSBI) at EPFL, “These discoveries can be so far ahead of the curve that...